Tabula Rasa HealthCare Inc

Tabula Rasa HealthCare Inc

Health CareHealth Care Providers
  • Price (USD)5.40
  • Today's Change0.20 / 3.85%
  • Shares traded46.32k
  • 1 Year change-6.25%
  • Beta1.5735
Data delayed at least 15 minutes, as of Mar 31 2023 19:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tabula Rasa HealthCare, Inc. is a healthcare technology company. The Company operates through two segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. PACE is a Centers for Medicare & Medicaid Services (CMS) sponsored program. The MedWise HealthCare segment provides technology-enabled solutions to promote medication safety and adherence to improve patient outcomes and reduce healthcare costs. The technology-enabled solutions revenue model is primarily based on payments on a PMPM basis, payments on a subscription basis, and payments on a fee-for-service basis for each medication safety review and clinical assessment completed.

  • Revenue in USD (TTM)299.52m
  • Net income in USD-77.33m
  • Incorporated2014
  • Employees1.03k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Yoshitsu Co Ltd (ADR)228.44m3.27m34.80m54.009.590.787.720.15230.10010.10017.591.231.936.605.17--2.77--6.53--17.10--1.43--
Homology Medicines Inc3.21m-5.01m54.62m92.00--0.305930.6917.03-0.0992-0.09920.05583.100.0146----34,869.570.2195-31.220.2413-33.71----15.06-818.17----0.00---90.56--94.77---8.08--
China Jo-Jo Drugstores Holdings Inc158.63m-3.52m89.81m911.00--1.01--0.5662-0.9731-0.973139.594.361.456.969.90174,127.50-3.22-8.29-9.51-23.5523.9822.07-2.22-5.890.7688--0.5619--23.4815.0760.69---5.73--
Rite Aid Corp24.06bn-897.69m122.09m53.00k------0.0051-16.50-16.50441.76-7.142.729.8014.50454,045.10-10.14-3.96-15.04-5.7719.9321.12-3.73-1.580.60090.34731.14--2.181.39-438.10---5.56--
Marimed Inc134.01m13.47m135.22m592.,368.309.89-16.3912.11-22.2247.7351.6910.16-19.660.931331.090.2425--10.3385.7086.42---9.49--
Tabula Rasa HealthCare Inc299.52m-77.33m139.73m1.03k------0.4665-3.18-6.0912.34-2.100.67838.737.37291,641.70-17.50-12.88-21.86-15.3122.3428.68-25.82-20.931.60-5.981.22--15.2517.54-48.04--34.14--
Petmed Express Inc260.45m11.40m335.24m212.0028.352.5122.901.290.56090.560912.826.341.567.49162.231,228,552.006.8419.338.2623.2828.0431.074.3810.543.59--0.0072.36-11.581.87-31.05-2.40-30.249.57
Data as of Mar 31 2023. Currency figures normalised to Tabula Rasa HealthCare Inc's reporting currency: US Dollar USD

Institutional shareholders

51.46%Per cent of shares held by top holders
HolderShares% Held
Indaba Capital Management LPas of 31 Dec 20226.52m24.04%
Apo Asset Management GmbHas of 28 Feb 20231.33m4.90%
UBS Securities LLCas of 31 Dec 20221.30m4.80%
The Vanguard Group, Inc.as of 31 Dec 20221.19m4.37%
Kennedy Capital Management, Inc.as of 31 Dec 2022971.74k3.58%
Baillie Gifford & Co.as of 31 Dec 2022831.69k3.07%
Repertoire Partners LPas of 31 Dec 2022549.80k2.03%
Jacobs Levy Equity Management, Inc.as of 31 Dec 2022478.16k1.76%
BlackRock Fund Advisorsas of 31 Dec 2022438.47k1.62%
Fuller & Thaler Asset Management, Inc.as of 31 Dec 2022351.94k1.30%
More ▼
Data from 31 Dec 2022 - 28 Feb 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.